Insider trade

Incyte (INCY): Director sold ~$1.42M

Paul J Clancy, Director at Incyte, sold ~$1.42M of Incyte shares.

~$1.42M
Approx. value · 15K sh @ $94.93
24K
Holds after · shares reported
Traded
May 19, 2026
Filed
May 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 25, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 25, 2026, Incyte Corporation (the “Company”) announced title changes for certain current members of its executive leadership team, effective immediately.”
  2. Mar 26, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 26, 2026, Susanne Schaffert notified Incyte Corporation (the “Company”) that she was resigning from the Company’s Board of Directors (the “Board”), effective as of April 15, 2026.”
  3. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Mar 30, 2026FDAFDA drug approval: Zynyz
  5. Apr 17, 2026Insider · 11 days before resultsOfficer sold ~$1.8M of INCY shares in the open market
  6. Apr 28, 2026Company filing · Form 8-K · ResultsReported its results
  7. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.3%
  8. May 1, 2026FDAFDA drug approval: Jakafi XR
  9. May 11, 20265% stakeFelix J. Baker filed an activist stake (13D) of 15.6%
  10. May 14, 20265% stakeDodge & Cox reported a passive stake (13G) of 6.2%
  11. May 18, 2026FDAFDA drug approval: Zynyz
  12. May 19, 2026 · this disclosureInsiderDirector sold ~$1.42M of INCY shares in the open market

What came next

  1. May 26, 2026InsiderOfficer sold ~$200K of INCY shares in the open market
  2. Jun 4, 2026InsiderOfficer sold ~$264K of INCY shares in the open market
  3. Jul 15, 2026Insider · 13 days before resultsOfficer sold ~$3.19M of INCY shares in the open market
  4. Jul 16, 2026Insider · 2 peopleInsiders: 2 sales (~$341K)
  5. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
  6. Jul 31, 2026Insider · 2 peopleInsiders: 12 sales (~$6.9M)
  7. Aug 3, 2026InsiderOfficer sold ~$729K of INCY shares in the open market
  8. Aug 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.6M)
  9. Aug 12, 2026InsiderOfficer sold ~$1.3M of INCY shares in the open market
  10. Aug 19, 2026InsiderOfficer sold ~$1.36M of INCY shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Incyte

For Incyte, OQRO holds 24 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INCY page.

How this filing works

Explore the data

Common questions

Which Incyte (INCY) insider traded, and how much?

Paul J Clancy, Director at Incyte, sold ~$1.42M of Incyte shares. 15K shares at $94.93.

When did it happen, and when was it made public?

Traded: May 19, 2026. Filed: May 21, 2026. That is 2 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Incyte recently?

For Incyte, OQRO holds 24 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the INCY page.

Does this mean INCY stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Incyte

Everything OQRO holds on this company is on its INCY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data